Stuyvesant Capital Management’s Medtronic MDT Stock Holding History

Stuyvesant Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-26,550	Closed	-$2.36M	–	31
2017 Q2	$2.36M	Hold	26,550	–	–	4.65%	11
2017 Q1	$2.14M	Hold	26,550	–	–	4.51%	13
2016 Q4	$1.89M	Hold	26,550	–	–	4.07%	15
2016 Q3	$2.29M	Sell	26,550 -1,000	-4%	-$87.1K	5.33%	9
2016 Q2	$2.39M	Sell	27,550 -100	-0.4%	-$8.09K	4.73%	10
2016 Q1	$2.07M	Sell	27,650 -800	-3%	-$60.3K	4.57%	11
2015 Q4	$2.19M	Sell	28,450 -50	-0.2%	-$3.76K	5.5%	8
2015 Q3	$1.91M	Sell	28,500 -1,650	-5%	-$122K	4.82%	10
2015 Q2	$2.23M	Sell	30,150 -250	-0.8%	-$19.1K	4.87%	9
2015 Q1	$2.37M	Hold	30,400	–	–	5.4%	7
2014 Q4	$2.19M	Hold	30,400	–	–	5.07%	9
2014 Q3	$1.88M	Hold	30,400	–	–	3.77%	12
2014 Q2	$1.94M	Sell	30,400 -1,600	-5%	-$97.2K	3.72%	13
2014 Q1	$1.97M	Sell	32,000 -1,050	-3%	-$61.2K	3.66%	14
2013 Q4	$1.9M	Hold	33,050	–	–	3.47%	14
2013 Q3	$1.76M	Sell	33,050 -400	-1%	-$21.5K	3.43%	15
2013 Q2	$1.72M	Buy	+33,450	New	+$1.65M	3.59%	14

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Stuyvesant Capital Management's MDT Position: Q3 2017 in Review

Stuyvesant Capital Management sold out of Medtronic (MDT) in Q3 2017, closing a stake of 26,550 shares — an estimated $2.36M sold.

Stuyvesant Capital Management first reported a position in MDT in Q2 2013 and held it in 17 quarters. The position peaked at $2.39M in Q2 2016. 1,290 funds tracked by Wall St. Rank hold MDT as of Q3 2017.

Stuyvesant Capital Management reported no remaining Medtronic position as of Q3 2017 after selling out during the quarter.
Stuyvesant Capital Management sold 26,550 Medtronic shares in Q3 2017, an estimated $2.36M.
Stuyvesant Capital Management first reported a position in Medtronic in Q2 2013 and held it in 17 quarters.
Stuyvesant Capital Management's Medtronic position peaked at $2.39M in Q2 2016.
1,290 funds tracked by Wall St. Rank held Medtronic as of Q3 2017.

Based on Stuyvesant Capital Management's 13F filing for Q3 2017, filed 7 Nov 2017.